Bafna Pharma Financials
NSE: BAFNAPH | BSE: 532989
₹301.85
₹-6.15
(-2.00%)
As on 03-Sep-2026 15:16IST
Market cap
₹716 Cr
Revenue (TTM)
₹143 Cr
P/E Ratio
91.9
P/B Ratio
7.4
Div. Yield
0 %
loading...
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
142.58
|
150.62
|
145.86
|
152.47
|
115.35
|
85.14
|
|
|
|
|
|
|
Total Income
|
148.65
|
155.49
|
148.90
|
155.99
|
118.62
|
86.90
|
|
|
|
|
|
|
Total Expenditure
|
130.81
|
134.79
|
134.98
|
141.35
|
99.63
|
73.24
|
|
|
|
|
|
|
EBITDA
|
11.76
|
15.83
|
10.88
|
11.11
|
15.72
|
11.90
|
|
|
|
|
|
|
Depreciation
|
6.48
|
6.07
|
4.89
|
5.00
|
5.33
|
5.49
|
|
|
|
|
|
|
EBIT
|
5.28
|
9.76
|
5.99
|
6.12
|
10.38
|
6.41
|
|
|
|
|
|
|
Interest
|
3.69
|
3.66
|
2.73
|
2.29
|
2.04
|
0.79
|
|
|
|
|
|
|
Other Income
|
6.07
|
4.87
|
3.04
|
3.52
|
3.27
|
1.76
|
|
|
|
|
|
|
Exceptional Items
|
--
|
--
|
-2.15
|
--
|
--
|
-2.16
|
|
|
|
|
|
|
Profit before Tax
|
7.66
|
10.97
|
4.15
|
7.35
|
11.62
|
5.22
|
|
|
|
|
|
|
Provision for Tax
|
-0.13
|
-0.13
|
--
|
--
|
0.28
|
--
|
|
|
|
|
|
|
Profit after Tax
|
7.79
|
11.10
|
4.15
|
7.35
|
11.34
|
5.22
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
96.15
|
96.15
|
84.81
|
80.84
|
73.45
|
61.96
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Non-Current Liabilities
|
22.19
|
22.19
|
16.42
|
12.76
|
9.65
|
6.17
|
|
|
|
|
|
|
Current Liabilities
|
57.19
|
57.19
|
51.85
|
54.08
|
46.48
|
22.01
|
|
|
|
|
|
|
Total Liabilities
|
175.53
|
175.53
|
153.08
|
147.68
|
129.58
|
90.14
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
84.93
|
85.88
|
66.90
|
53.91
|
42.27
|
39.26
|
|
|
|
|
|
|
Current Assets
|
89.65
|
89.65
|
84.73
|
93.77
|
87.31
|
50.88
|
|
|
|
|
|
|
Total Assets
|
175.53
|
175.53
|
153.08
|
147.68
|
129.58
|
90.14
|
|
|
|
|
|
|
Total Debt*
|
--
|
37.43
|
28.20
|
24.39
|
22.92
|
11.06
|
|
|
|
|
|
|
Net Current Assets
|
32.46
|
32.46
|
32.88
|
39.69
|
40.84
|
28.87
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
20.24
|
17.33
|
17.54
|
10.48
|
6.17
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
15.37
|
22.14
|
9.48
|
4.95
|
9.73
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-22.40
|
-21.16
|
-15.05
|
-7.49
|
-6.54
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
5.62
|
1.06
|
-0.85
|
10.18
|
-4.81
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
-1.41
|
2.04
|
-6.41
|
7.64
|
-1.63
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
3.29
|
4.69
|
1.76
|
3.11
|
4.79
|
2.21
|
|
|
|
|
|
|
Cash EPS (₹)
|
3.29
|
7.26
|
3.82
|
5.22
|
7.05
|
4.53
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
40.68
|
40.64
|
35.85
|
34.17
|
31.05
|
26.19
|
|
|
|
|
|
|
Dividend per Share (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
6.50
|
9.36
|
4.01
|
2.09
|
4.11
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
-5.64
|
-2.23
|
-3.60
|
-1.89
|
1.00
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
11.87
|
6.31
|
9.56
|
16.12
|
8.42
|
|
|
|
|
|
|
ROE (%)
|
8.31
|
12.27
|
5.01
|
9.52
|
16.75
|
8.79
|
|
|
|
|
|
|
ROA (%)
|
4.74
|
6.76
|
2.76
|
5.30
|
10.32
|
5.91
|
|
|
|
|
|
|
EBIT Margin (%)
|
3.70
|
6.48
|
4.10
|
4.01
|
9.00
|
7.53
|
|
|
|
|
|
|
Net Margin (%)
|
5.24
|
7.14
|
2.79
|
4.71
|
9.56
|
6.00
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
11.40
|
6.20
|
8.10
|
14.45
|
12.58
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-3.14
|
3.26
|
-4.33
|
32.18
|
35.48
|
19.55
|
|
|
|
|
|
|
EBIT Growth (%)
|
-48.35
|
62.98
|
-2.12
|
-41.09
|
61.93
|
10.16
|
|
|
|
|
|
|
Net Profit Growth (%)
|
-22.63
|
167.30
|
-43.49
|
-35.19
|
117.34
|
-10.47
|
|
|
|
|
|
|
EPS Growth (%)
|
-5.78
|
167.31
|
-43.49
|
-35.19
|
117.34
|
-10.47
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
13.38
|
4.91
|
10.05
|
18.54
|
9.15
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
91.90
|
24.08
|
42.73
|
24.68
|
17.24
|
57.59
|
|
|
|
|
|
|
Price / Book Value
|
7.44
|
2.78
|
2.09
|
2.24
|
2.66
|
4.85
|
|
|
|
|
|
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
EV/EBITDA
|
42.12
|
14.62
|
14.53
|
13.96
|
11.09
|
22.79
|
|
|
|
|
|
|
Close Price (₹)
|
214.63
|
109.34
|
74.80
|
78.35
|
82.00
|
126.65
|
|
|
|
|
|
|
High Price (₹)
|
218.70
|
204.95
|
113.00
|
125.55
|
141.00
|
190.70
|
|
|
|
|
|
|
Low Price (₹)
|
77.01
|
70.61
|
67.80
|
75.90
|
77.05
|
113.30
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
715.72
|
267.32
|
177.42
|
181.34
|
195.52
|
300.44
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.18
|
0.39
|
0.33
|
0.30
|
0.31
|
0.18
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
0.12
|
0.10
|
0.12
|
0.16
|
0.07
|
|
|
|
|
|
|
Current Ratio
|
1.57
|
1.57
|
1.63
|
1.73
|
1.88
|
2.31
|
|
|
|
|
|
|
Quick Ratio
|
1.06
|
1.06
|
1.09
|
1.19
|
1.40
|
1.39
|
|
|
|
|
|
|
Interest Coverage
|
3.07
|
4.00
|
2.52
|
4.21
|
6.70
|
7.57
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
30.81
|
29.17
|
27.54
|
29.77
|
35.67
|
17.36
|
|
|
|
|
|
|
Asset Turnover
|
0.87
|
0.92
|
0.97
|
1.10
|
1.05
|
0.96
|
|
|
|
|
|
|
Receivable days
|
--
|
101.91
|
107.07
|
103.59
|
88.49
|
52.17
|
|
|
|
|
|
|
Inventory Days
|
--
|
69.05
|
72.23
|
62.08
|
67.24
|
76.57
|
|
|
|
|
|
|
Payable days
|
--
|
138.54
|
149.66
|
134.43
|
118.26
|
105.56
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
32.41
|
29.64
|
31.24
|
37.47
|
23.18
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
